EX1
Pharmaceuticals, Biotechnology & Life Sciences
Exopharm
- Short interest
- 0.00%
- −0.01 pp 30d
- as of 12 Dec 2022
- Reported shorts
- 6.5K
- Shares on issue
- 157.212M
Exopharm (EX1) strategy fit
Market regime · S&P/ASX 200 (XJO)
Downtrendas of
- Close
- 8,719.7
- vs 50-day
- −1.8%
- vs 200-day
- −1.2%
- Off 52w high
- −6.2%
Downtrend: XJO is below its 200-day average.
Not evaluated yet
The picker reads a stock only with at least 60 sessions of price history in the last 400 days, and it holds fewer than that for EX1 today. See what it does read on the stock picker.
Prices to 15 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial advice